Navigation Links
Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
Date:6/8/2009

President, Global Head, Novartis Oncology Development. "These latest data show an antitumor effect in lymphoma that support the rationale for a Phase III study of Afinitor to prevent relapse in patients with diffuse large B-cell lymphoma, where there is a significant unmet medical need."

Novartis has initiated PILLAR-2 (PIvotaL Lymphoma triAls of RAD001), a Phase III trial investigating adjuvant treatment with everolimus (RAD001) in poor-risk patients with DLBCL who achieved complete remission with first-line rituximab combined with chemotherapy. This worldwide study will evaluate the potential of everolimus to extend disease-free survival in patients with DLBCL. The longer a patient with DLBCL is in remission the higher their likelihood to remain disease-free. There is no approved therapy for the approximately 50% of patients who will relapse after achieving a complete response on initial treatment, demonstrating an important unmet need(6).

EHA study details

The proof-of-concept, open-label, single-arm, multicenter Phase II study was designed to assess the efficacy and safety of everolimus in patients with relapsed/refractory aggressive or indolent NHL or Hodgkin's disease whose disease progressed despite prior treatment. Patients had received a median of four prior therapies (between one and 15 therapies). The study included patients with T-cell non-Hodgkin's lymphoma, Hodgkin's disease, follicular lymphoma, mantle cell lymphoma, DLBCL and small lymphocytic lymphoma; all of whom had experienced disease progression despite prior treatment. The primary endpoint of the study is to assess ORR. Secondary endpoints include assessment of progression-free survival (PFS), overall survival, time to disease progression and the safety profile of Afinitor(1).

In the trial, everolimus showed anticancer activity across multiple types of lymphoma, including T-cell non
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... LA JOLLA, Calif. , June 1, 2015 ... RGLS ), a biopharmaceutical company leading the discovery ... today that Kleanthis G. Xanthopoulos , Ph.D. ... and as a member of Regulus, Board of ... the biotechnology industry.  Paul Grint, M.D., who previously ...
(Date:6/1/2015)... , June 1, 2015 ... weight over large area and improve the quality life ... ulcer. These devices play a significant role in inhibiting ... reduce the need to turn or rotate an immobile ... include mattress, mattresses overlay, and specialty beds. These devices ...
(Date:6/1/2015)... , June 1, 2015 NEOVIA ... company engaged in the development and commercialization of ... that it has met with the U.S. Food ... the filing of an Investigational New Drug (IND) ... As a result of the meeting, Neovia has ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3Neovia Oncology Announces First IND Meeting 2
... Nov. 29, 2011 Hamamatsu Photonics introduces ... exceptional quantum efficiency and low noise, the ... cooled CCDs, and first-generation scientific CMOS cameras. ... Now one camera covers a wide range ...
... Ala., Nov. 28, 2011 Qualitest Pharmaceuticals today announced that ... (Levonorgestrel and Ethinyl Estradiol Tablets, USP), 0.05 mg/0.03 mg, 0.075 ... The total sales for Myzilra Tablets in the ... approximately $34.4 million, according to IMS Health. ...
Cached Medicine Technology:Hamamatsu Introduces the ORCA-Flash4.0 Scientific CMOS Camera With High Sensitivity, High Resolution, and Fast Readout 2
(Date:6/1/2015)... Unlike most generator rental companies, which raise their rates by ... when the generator is in standby mode, WPP charges a ... or not. WPP also offers an offsite storage option — ... few hours — for companies that do not have the ... “Even minor business disruptions are very expensive for commercial and ...
(Date:6/1/2015)... On May 14, 2015, the AFC/Doctors Express ... Creek Chamber of Commerce for the grand opening of ... do not offer primary care services by appointment; the ... Care staff to schedule family care procedures, such as ... p.m. the center hosted presidents, CEOs, and managers from ...
(Date:6/1/2015)... a leading web-base electronic healthcare software (EHR) is providing ... Louisiana. The entrepreneurial trio behind Sharenote, will travel to ... with the tools and resources to monitor key performance ... , Find out why Sharenote is the EHR ... 250 practices. , Four Day Schedule , ...
(Date:6/1/2015)... Peoria, IL (PRWEB) June 01, 2015 There’s ... doctor, especially when it comes to non-emergency, minor illnesses. , ... OnCall , 24/7 online access to medical care via the ... it via smartphone, tablet or computer. , “Everyone is busy. ... sometimes be a challenge, so we want to make it ...
(Date:6/1/2015)... Hexagon Geospatial is pleased to announce the ... subscription service that provides on-demand access to the company’s ... ERDAS IMAGINE and GeoMedia are now ... a subscription model for delivering software products as an ... to quickly and easily access the right tools that ...
Breaking Medicine News(10 mins):Health News:Worldwide Power Products Offers “Budget Billing” Contingency Generator Rental Program; Guarantees Power for Peak of Hurricane Season and Beyond 2Health News:Grand Opening For AFC/Doctors Express Cherry Creek Primary Care Clinic 2Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3
... benefits for ... communities across America, WASHINGTON, March 27 At the ... National Council on Aging,(NCOA) announced a three-year extension of their ... Their joint,"Prescription for Better Health" program, underway since 2007, provides,improved ...
... Respect, Thanks, - Peake, Fourth National Summit on ... 27 Recognizing the valor,service and sacrifice of America,s ... has created a comprehensive array of,benefits and programs., ... veterans of World,War II, Korea, Vietnam, the Gulf War, ...
... LONDON, March 27 NHS Choices ( http://www.nhs.uk ), ... Live Well bundle aimed to,help people look after their ... online magazine,( http://www.nhs.uk/Livewell/foothealth/Pages/Foothealthhome.aspx ) enables,users to find information about ... most common foot problems and how to treat them, ...
... Support Health Plans Next Generation of Care Management ... and Special Need Populations, SAN ANTONIO and AUBURN, ... only locally owned and operated,non-profit HMO, announced today that ... to support its next,generation of care management programs sponsored ...
... Tracy Rupp has won the 2008 National Sleep Foundation ... from young sleep researchers (i.e., within 5 years of ... National Sleep Foundation (NSF). Each submission was rated by ... these abstracts, the top 16 were chosen (8 "clinical ...
... Tobacco Advertising and Find It,Easy to Buy Cigarettes, ... tobacco on April 2 as they join thousands of ... sponsored by the,Campaign for Tobacco-Free Kids. Hundreds of events ... events, go to, http://www.kickbuttsday.org/events )., This year, Kick ...
Cached Medicine News:Health News:CVS/pharmacy and the National Council on Aging Extend 'Prescription for Better Health' Partnership 2Health News:CVS/pharmacy and the National Council on Aging Extend 'Prescription for Better Health' Partnership 3Health News:VA Reaches Out to Women Veterans 2Health News:VA Reaches Out to Women Veterans 3Health News:Community First Health Plans Selects TCS Healthcare Technologies' Care Management Software System 2Health News:Community First Health Plans Selects TCS Healthcare Technologies' Care Management Software System 3Health News:Virginia Kids 'Kick Butts' on April 2 2Health News:Virginia Kids 'Kick Butts' on April 2 3
... The Accommodating Intraocular Lens is for the treatment ... in many middle aged and older patients. , ... in the natural lens of the eye as ... less elastic. With less elasticity, the eye has ...
Designed with your input, the ATS Simulus™ flexible annuloplasty ring and band are easy endings to complex mitral valve repairs....
The Victory single- and dual-chamber rate-responsive pacemakers from St. Jude Medical are advanced-feature systems, designed to save valuable clinic time, maximize patient safety, and provide other t...
... right for the not-so-typical patient. , With ... ability to address the atypical situations that ... after implant. St. Jude Medical ICDs feature ... in almost any situation, from high defibrillation ...
Medicine Products: